Humana AB (publ) Market Cap ($362.58 Million)
Market Cap & Net Worth: Humana AB (publ) (HUM)
Humana AB (publ) market cap. Humana AB (publ) (ST:HUM) has a market capitalization of $362.58 Million (Skr3.37 Billion) as of November 1, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #13584 globally and #227 in its home market, demonstrating a 1.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Humana AB (publ)'s stock price Skr70.90 by its total outstanding shares 47521133 (47.52 Million). Also see HUM cash flow metrics for how efficiently the company converts equity into cash flow.
Humana AB (publ) Market Cap History (2016–2026)
Humana AB (publ) market cap history from 2016 to 2026. Data shows change from $356.10 Million to $362.58 Million (-0.12% CAGR). Check latest Humana AB (publ) stock price today for real-time trading data and today's change.
Humana AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Humana AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore HUM net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.03x
Humana AB (publ)'s market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.09x
Humana AB (publ)'s market cap is 1.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $356.10 Million | $6.36 Billion | $148.00 Million | 0.06x | 2.41x |
| 2017 | $275.10 Million | $6.54 Billion | $194.00 Million | 0.04x | 1.42x |
| 2018 | $303.15 Million | $6.71 Billion | $245.00 Million | 0.05x | 1.24x |
| 2019 | $311.44 Million | $7.45 Billion | $188.00 Million | 0.04x | 1.66x |
| 2020 | $302.75 Million | $7.77 Billion | $262.00 Million | 0.04x | 1.16x |
| 2021 | $371.79 Million | $8.19 Billion | $276.00 Million | 0.05x | 1.35x |
| 2022 | $196.89 Million | $9.20 Billion | $210.00 Million | 0.02x | 0.94x |
| 2023 | $143.96 Million | $9.65 Billion | $176.00 Million | 0.01x | 0.82x |
| 2024 | $182.32 Million | $10.29 Billion | $144.00 Million | 0.02x | 1.27x |
| 2025 | $257.75 Million | $10.01 Billion | $237.00 Million | 0.03x | 1.09x |
Competitor Companies of HUM by Market Capitalization
Companies near Humana AB (publ) in the global market cap rankings as of November 1, 2026. Also see total assets of Humana AB (publ) for a full breakdown of the balance sheet.
Key companies related to Humana AB (publ) by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #901 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #987 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1210 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $473.19 |
| #901 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.80 |
| #987 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1210 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $273.25 |
Market Capitalization of Humana AB (publ) (2016–2026)
Market capitalization of Humana AB (publ) from 2016 to today. Between 2016 and today, Humana AB (publ)'s market cap moved from $356.10 Million to $ 362.58 Million, with a yearly change of -0.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr362.58 Million | +40.67% |
| 2025 | Skr257.75 Million | +41.37% |
| 2024 | Skr182.32 Million | +26.64% |
| 2023 | Skr143.96 Million | -26.88% |
| 2022 | Skr196.89 Million | -47.04% |
| 2021 | Skr371.79 Million | +22.80% |
| 2020 | Skr302.75 Million | -2.79% |
| 2019 | Skr311.44 Million | +2.74% |
| 2018 | Skr303.15 Million | +10.19% |
| 2017 | Skr275.10 Million | -22.75% |
| 2016 | Skr356.10 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Humana AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $362.58 Million USD |
| MoneyControl | $362.58 Million USD |
| MarketWatch | $362.58 Million USD |
| marketcap.company | $362.58 Million USD |
| Reuters | $362.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Humana AB (publ)
Humana AB (publ) provides individual and family care services for children and adults in Sweden, Finland, Norway, and Denmark. The company operates through three segments: Sweden, Finland, and Norway. It provides care and treatment for psychosocial disorders, mental illness, and functional impairment; residential care homes; family care services; short-term, short term housing, day care, and spec… Read more